Pharmacological adjuncts and transcranial magnetic stimulation-induced synaptic plasticity: a systematic review
Journal of Psychiatry and Neuroscience · 15.02.2024 · 49 (1) · E59-E76
DOI: 10.1503/jpn.230090 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Psychiatry and Neuroscience, erschienen am 15.02.2024. Verfasst von Myren N Sohn und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the Hotchkiss Brain Institute, University of Calgary, Calgary, Alta., Canada (Sohn, McGirr); the Department of Psychiatry, University of Calgary…. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Neuronal Plasticity. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Transcranial magnetic stimulation (TMS) is a noninvasive neurostimulation modality that has been used to study human synaptic plasticity. Leveraging work in ex vivo preparations, mechanistically informed pharmacological adjuncts to TMS have been used to improve our fundamental understanding of TMS-induced synaptic plasticity.
Methods
We systematically reviewed the literature pairing pharmacological adjuncts with TMS plasticity-induction protocols in humans. We searched MEDLINE, PsycINFO, and Embase from 2013 to Mar. 10, 2023. Studies published before 2013 were extracted from a previous systematic review. We included studies using repetitive TMS, theta-burst stimulation, paired associative stimulation, and quadripulse stimulation paradigms in healthy and clinical populations.
Results
Thirty-six studies met our inclusion criteria (28 in healthy and 8 in clinical populations). Most pharmacological agents have targeted the glutamatergic N-methyl-d-aspartate (NMDA; 15 studies) or dopamine receptors (13 studies). The NMDA receptor is necessary for TMS-induced plasticity; however, sufficiency has not been shown across protocols. Dopaminergic modulation of TMS-induced plasticity appears to be dose-dependent. The GABAergic, cholinergic, noradrenergic, and serotonergic neurotransmitter systems have small evidence bases supporting modulation of TMS-induced plasticity, as do voltage-gated calcium and sodium channels. Studies in clinical populations suggest that pharmacological adjuncts to TMS may rescue motor cortex plasticity, with implications for therapeutic applications of TMS and a promising clinical trial in depression.
Limitations
This review is limited by the predominance in the literature of studies with small sample sizes and crossover designs.
Conclusion
Pharmacologically enhanced TMS largely parallels findings from ex vivo preparations. As this area expands and novel targets are tested, adequately powered samples in healthy and clinical populations will inform the mechanisms of TMS-induced plasticity in health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Hotchkiss Brain Institute, University of Calgary, Calgary, Alta., Canada (Sohn, McGirr); the Department of Psychiatry, University of Calgary, Alta., Canada (Sohn, McGirr); the Mathison Centre for Mental Health…
Zitieren
APA
Sohn, M. N., Brown, J. C., Sharma, P., Ziemann, U., & McGirr, A. (2024). Pharmacological adjuncts and transcranial magnetic stimulation-induced synaptic plasticity: a systematic review. Journal of Psychiatry and Neuroscience, 49(1), E59-E76. https://doi.org/10.1503/jpn.230090
Vancouver
Sohn MN, Brown JC, Sharma P, Ziemann U, McGirr A. Pharmacological adjuncts and transcranial magnetic stimulation-induced synaptic plasticity: a systematic review. Journal of Psychiatry and Neuroscience. 2024;49(1):E59-E76. doi:10.1503/jpn.230090
BibTeX
@article{Sohn2024,
author = {Sohn, Myren N and Brown, Joshua C and Sharma, Prayushi and Ziemann, Ulf and McGirr, Alexander},
title = {Pharmacological adjuncts and transcranial magnetic stimulation-induced synaptic plasticity: a systematic review},
journal = {Journal of Psychiatry and Neuroscience},
year = {2024},
volume = {49},
number = {1},
pages = {E59--E76},
doi = {10.1503/jpn.230090}
}
EUVIMED